☆ 4.6 Article

Stereotactic Radiosurgery for Lung Cancer with a Risk-Adapted Strategy Using the Volumetric Modulated Arc Therapy Technique: A Single Arm Phase II Study

CANCERS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Oncology

Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done

Austin J. Bartl et al.

Summary: The adoption of single-fraction stereotactic body radiation therapy for lung tumors has been limited in various institutions, even during the COVID-19 pandemic. Lack of familiarity and concerns about potential toxicities may be reasons for this limitation. To address this issue, a systematic review of prospective studies on single-fraction SBRT was conducted. The review found that the use of single-fraction SBRT showed favorable outcomes in terms of local control and survival among peripheral tumors. Toxicities were generally mild, with a small percentage of patients experiencing severe toxicity. These encouraging results suggest that single-fraction SBRT may be beneficial beyond the current pandemic.

CANCERS (2022)

添加到收藏夹

Article Oncology

Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer

Michael J. Zelefsky et al.

Summary: This study demonstrates that ultra high single-dose radiation therapy (24 Gy SDRT) is more effective in improving local control of oligometastatic lesions compared to standard hypofractionated stereotactic body radiation therapy (3 x 9 Gy SBRT), leading to reduced rates of local recurrence and distant metastatic progression.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Sample size calculations for single-arm survival studies using transformations of the Kaplan-Meier estimator

Kengo Nagashima et al.

Summary: This study proposed alternative methods to determine sample sizes based on a valid standard normal approximation, which may provide accurate results even with small sample sizes. Through numerical evaluations via simulations, some of the proposed methods were more accurate, with the method using the arcsine square-root transformation tending to be closer to a prescribed power.

PHARMACEUTICAL STATISTICS (2021)

添加到收藏夹

Article Oncology

Ten-Year Experience in Implementing Single-Fraction Lung SBRT for Medically Inoperable Early-Stage Lung Cancer

Gregory M. M. Videtic et al.

Summary: The review of ten years of using single-fraction lung stereotactic body radiation therapy for medically inoperable early-stage lung cancer found high survival rates and low toxicity reactions, with no significant differences in outcomes between different dosage levels.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

添加到收藏夹

Article Oncology

A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors: a comparison between two antipodal fractionations

F. Alongi et al.

Summary: The study found that single fraction and multi-fraction SBRT treatments show similar safety and efficacy in treating primary inoperable lung tumors, especially for smaller lesions. Single fraction may be preferred to reduce patient hospital visits without negatively impacting tumor control and survival.

CLINICAL & TRANSLATIONAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II) The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial

Shankar Siva et al.

Summary: This multicenter randomized clinical trial comparing single-fraction and multifraction SABR for pulmonary oligometastases showed no significant differences in adverse events, local control, and survival outcomes between the two arms. Single-fraction SABR was found to be more efficient in delivery and could be considered for further studies based on the most acceptable outcome profile.

JAMA ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Organ at Risk Dose Constraints in SABR : A Systematic Review of Active Clinical Trials

Serenna G. Gerhard et al.

Summary: There is substantial variability in OAR dose constraints used in current clinical trials evaluating SABR for oligometastatic disease, with no clear preferred dose constraints identified. Future research and development of standardized OAR dose constraints are recommended for the field of radiation oncology.

PRACTICAL RADIATION ONCOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Implementation of Single-Fraction Lung Stereotactic Ablative Radiotherapy in a Multicenter Provincial Cancer Program During the COVID-19 Pandemic

Benjamin Mou et al.

Summary: The implementation of single-fraction lung stereotactic ablative radiotherapy (SF lung SABR) was quickly adopted by a provincial cancer program in British Columbia during the COVID-19 pandemic. While consensus guidelines were written and approved in a timely manner, the progress of implementation varied among individual centers due to differences in resources and staffing. Strong organizational structures and early identification of potential barriers are essential for the efficient implementation of new treatment initiatives in large multicenter radiotherapy programs.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

添加到收藏夹

Article Oncology

Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II)

Shankar Siva et al.

Summary: This study aimed to compare the treatment efficacy of single-fraction and multifraction SABR for pulmonary oligometastases, and the results showed no significant differences in safety, efficacy, or symptom burden between the two approaches, with single-fraction SABR being more efficient for delivery.

JAMA ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival

Takaya Yamamoto et al.

BMC CANCER (2020)

添加到收藏夹

Article Oncology

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial

David Ball et al.

LANCET ONCOLOGY (2019)

添加到收藏夹

Article Oncology

One Versus Three Fractions of Stereotactic Body Radiation Therapy for Peripheral Stage I to II Non-Small Cell Lung Cancer: A Randomized, Multi-Institution, Phase 2 Trial

Anurag K. Singh et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

添加到收藏夹

Article Oncology

Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer

Gregory M. Videtic et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

添加到收藏夹

Article Biology

Possibility of chest wall dose reduction using volumetric-modulated arc therapy (VMAT) in radiation-induced rib fracture cases: comparison with stereotactic body radiation therapy (SBRT)

Yu Murakami et al.

JOURNAL OF RADIATION RESEARCH (2018)

添加到收藏夹

Article Oncology

Pooled Analysis of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)

Shankar Siva et al.

CANCER (2018)

添加到收藏夹

Article Oncology

Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models

Feng Liu et al.

RADIOTHERAPY AND ONCOLOGY (2017)

添加到收藏夹

Article Oncology

A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)

Gregory M. M. Videtic et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)

添加到收藏夹

Article Oncology

Stereotactic Body Radiotherapy Using a Radiobiology-Based Regimen for Stage I Non-Small-Cell Lung Cancer

Yuta Shibamoto et al.

JOURNAL OF THORACIC ONCOLOGY (2015)

添加到收藏夹

Article Oncology

Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors

Takaya Yamamoto et al.

BMC CANCER (2014)

添加到收藏夹

Article Oncology

Stereotactic Radiosurgery (SRS) with Volumetric Modulated Arc Therapy (VMAT): Interim Results of a Multi-arm Phase I Trial (DESTROY-2)

F. Deodato et al.

CLINICAL ONCOLOGY (2014)

添加到收藏夹

Article Oncology

30 Gy or 34 Gy? Comparing 2 Single-Fraction SBRT Dose Schedules for Stage I Medically Inoperable Non-Small Cell Lung Cancer

Gregory M. M. Videtic et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)

添加到收藏夹

Article Oncology

Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors

Atsushi Nambu et al.

BMC CANCER (2013)

添加到收藏夹

Article Biophysics

Investigation of the freely available easy-to-use software 'EZR' for medical statistics

Y. Kanda

BONE MARROW TRANSPLANTATION (2013)

添加到收藏夹

Article Oncology

DOSIMETRIC EVALUATION OF HETEROGENEITY CORRECTIONS FOR RTOG 0236: STEREOTACTIC BODY RADIOTHERAPY OF INOPERABLE STAGE I-II NON-SMALL-CELL LUNG CANCER

Ying Xiao et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)

添加到收藏夹

Article Oncology

Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors

R Hara et al.

CANCER (2006)

添加到收藏夹

Article Oncology

Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients

J Wulf et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.